Thomas Appio - Bausch Health President & Co-Head Bausch + Lomb/International
| BHC Stock | CAD 11.13 0.04 0.36% |
President
Mr. Thomas J. Appio is President CoHead Bausch LombInternational of the Company. He was previously our Executive Vice President, Company Group Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013, Mr. Appio served in several positions with Bausch Lomb, including as Vice President, North AsiaJapan and as Managing Director, Greater China and Japan. Prior to joining Bausch Lomb, Mr. Appio served 23 years with ScheringPlough in a wide range of leadership and operations responsibilities. Mr. Appio has spent nearly 20 years working in the Asia Pacific region since 2018.
| Age | 62 |
| Tenure | 6 years |
| Address | 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 |
| Phone | 514 744 6792 |
| Web | https://www.bauschhealth.com |
Thomas Appio Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Appio against Bausch Health stock is an integral part of due diligence when investing in Bausch Health. Thomas Appio insider activity provides valuable insight into whether Bausch Health is net buyers or sellers over its current business cycle. Note, Bausch Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bausch Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Appio over two months ago Disposition of 14683 shares by Thomas Appio of Bausch Health at 5.93 subject to Rule 16b-3 |
Bausch Health Management Efficiency
The company has return on total asset (ROA) of 0.0415 % which means that it generated a profit of $0.0415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.0454) %, meaning that it generated substantial loss on money invested by shareholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Equity is likely to grow to 0.61, though Return On Tangible Assets are likely to grow to (0.06). At this time, Bausch Health's Other Current Assets are very stable compared to the past year. As of the 25th of November 2024, Total Current Assets is likely to grow to about 5.9 B, while Total Assets are likely to drop about 14.9 B.Management Performance
| Return On Equity | -23.05 | ||||
| Return On Asset | 0.0415 |
Bausch Health Companies Leadership Team
Elected by the shareholders, the Bausch Health's board of directors comprises two types of representatives: Bausch Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Health's management team and ensure that shareholders' interests are well served. Bausch Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeff Hartness, Commercial Access | ||
| Kathleen Fitzpatrick, Executive Officer | ||
| John Barresi, Controller, VP | ||
| Garen Sarafian, VP Relations | ||
| Arthur Shannon, IR Contact Officer | ||
| Jiny MBA, Senior Medical | ||
| Tage MD, Chief RD | ||
| William Woodfield, Senior Treasurer | ||
| Donald Pearl, Senior Dermatologics | ||
| Robert Butz, VP Affairs | ||
| JeanJacques Charhon, Chief Officer | ||
| Mirza Dautbegovic, Executive COO | ||
| Aimee Lenar, Executive Pharma | ||
| Seana Carson, Executive Counsel | ||
| Josh Coyle, Senior Salix | ||
| Graham Jackson, Senior Officer | ||
| Thomas Appio, President & Co-Head Bausch + Lomb/International | ||
| Thomas Vadaketh, Ex CFO | ||
| Cees Heiman, Senior Canada |
Bausch Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bausch Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -23.05 | ||||
| Return On Asset | 0.0415 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 33.17 B | ||||
| Shares Outstanding | 367.8 M | ||||
| Shares Owned By Insiders | 11.08 % | ||||
| Shares Owned By Institutions | 71.40 % | ||||
| Number Of Shares Shorted | 3.27 M | ||||
| Price To Book | 18.74 X |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
| 0.78 | RY | Royal Bank | PairCorr |
| 0.8 | AMZN | Amazon CDR | PairCorr |
| 0.83 | BNS | Bank of Nova Scotia Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.